메뉴 건너뛰기




Volumn 75, Issue 10, 1997, Pages 1515-1518

Measurements of tissue polypeptide-specific antigen and prostate-specific antigen in prostate cancer patients under intermittent androgen suppression therapy

Author keywords

Intermittent androgen suppression; Prostate cancer; Prostate specific antigen; Tissue polypeptide specific antigen; Tumour marker

Indexed keywords

ANDROGEN; CYPROTERONE ACETATE; GOSERELIN; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE; TISSUE POLYPEPTIDE ANTIGEN;

EID: 0030989508     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.259     Document Type: Article
Times cited : (14)

References (19)
  • 1
    • 0027416692 scopus 로고
    • Effects of intermittent androgen suppression on androgen-dependent tumours: Apoptosis and serum prostale specific antigen
    • Akakura K, Bruchovsky N, Goldenberg SL, Rennie PS, Buckley AR and Sullivan LD (1993) Effects of intermittent androgen suppression on androgen-dependent tumours: apoptosis and serum prostale specific antigen. Cancer 71: 2782-2790
    • (1993) Cancer , vol.71 , pp. 2782-2790
    • Akakura, K.1    Bruchovsky, N.2    Goldenberg, S.L.3    Rennie, P.S.4    Buckley, A.R.5    Sullivan, L.D.6
  • 2
    • 0002499085 scopus 로고
    • On the nature and clinical use of tissue polypeptide antigen (TPA)
    • Bjorklund B (1980) On the nature and clinical use of tissue polypeptide antigen (TPA). Tumour Diagnostik 1: 9-20
    • (1980) Tumour Diagnostik , vol.1 , pp. 9-20
    • Bjorklund, B.1
  • 3
    • 0028061547 scopus 로고
    • From tissue polypeptide antigen to specific cytokeratin assays
    • Börmer OP (1994) From tissue polypeptide antigen to specific cytokeratin assays. Tumor Biol 9: 185-187
    • (1994) Tumor Biol , vol.9 , pp. 185-187
    • Börmer, O.P.1
  • 4
  • 5
    • 0029050259 scopus 로고
    • Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma
    • Bruchovsky N, Goldenberg SL, Rennie PS and Gleave M (1995) Theoretical considerations and initial clinical results of intermittent hormone treatment of patients with advanced prostatic carcinoma. Urologe-A 34: 389-392
    • (1995) Urologe-A , vol.34 , pp. 389-392
    • Bruchovsky, N.1    Goldenberg, S.L.2    Rennie, P.S.3    Gleave, M.4
  • 6
    • 0028804123 scopus 로고
    • Commentary on maximal androgen blockade in prostate cancer: A theory to put into practise?
    • Denis L (1995) Commentary on maximal androgen blockade in prostate cancer: a theory to put into practise? Prostate 27: 233-240
    • (1995) Prostate , vol.27 , pp. 233-240
    • Denis, L.1
  • 7
    • 0028817056 scopus 로고
    • Tissue polypeptide-speeific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours
    • Kornek G, Schenk T, Raderer M, Djavarnmad M and Scheithauer W (1995) Tissue polypeptide-speeific antigen (TPS) in monitoring palliative treatment response of patients with gastrointestinal tumours. Br J Cancer 71: 182-185
    • (1995) Br J Cancer , vol.71 , pp. 182-185
    • Kornek, G.1    Schenk, T.2    Raderer, M.3    Djavarnmad, M.4    Scheithauer, W.5
  • 8
    • 0000035768 scopus 로고    scopus 로고
    • Carcinoma of the prostate
    • Gillenwater JY, Grayhack JP, Howards SS and Duckett JW (eds), Yearbook Medical: Chicago
    • Kozlowski JM and Grayhack JP (1996) Carcinoma of the prostate. In Adult and Pediatric Urology. 3rd edn, Gillenwater JY, Grayhack JP, Howards SS and Duckett JW (eds), pp. 1679- 1689. Yearbook Medical: Chicago
    • (1996) Adult and Pediatric Urology. 3rd Edn , pp. 1679-1689
    • Kozlowski, J.M.1    Grayhack, J.P.2
  • 9
    • 0025915563 scopus 로고
    • Prostate specific antigen in hormonally treated D2 prostate cancer; is it always an accurate indicator of disease status?
    • Leo ME, Bilhartz DL, Bergstrahl EJ and Oesterling JE (1991) Prostate specific antigen in hormonally treated D2 prostate cancer; is it always an accurate indicator of disease status? J Urol 145: 802-807
    • (1991) J Urol , vol.145 , pp. 802-807
    • Leo, M.E.1    Bilhartz, D.L.2    Bergstrahl, E.J.3    Oesterling, J.E.4
  • 11
    • 0027473197 scopus 로고
    • Tissue polypeptide-specific antigen: A discriminative parameter between prostate cancer and benign prostatic hypertrophy
    • Marrink J, Oosterom R, Bonfrer HMG, Schröder FH, Mensink HJA (1993) Tissue polypeptide-specific antigen: a discriminative parameter between prostate cancer and benign prostatic hypertrophy. Eur J Cancer 29A: 570-571
    • (1993) Eur J Cancer , vol.29 A , pp. 570-571
    • Marrink, J.1    Oosterom, R.2    Bonfrer, H.M.G.3    Schröder, F.H.4    Mensink, H.J.A.5
  • 12
    • 0026525245 scopus 로고
    • The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer
    • Miller JL, Ahmann FR, Drach GW, Emerson SS and Bottacini MR (1992) The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer. J Urol 147: 956-961
    • (1992) J Urol , vol.147 , pp. 956-961
    • Miller, J.L.1    Ahmann, F.R.2    Drach, G.W.3    Emerson, S.S.4    Bottacini, M.R.5
  • 13
    • 0025869392 scopus 로고
    • Prostate specific antigen. A critical assessment of the most useful tumour marker tor adenocarcinoma of the prostate
    • Oesterling JE (1991) Prostate specific antigen. A critical assessment of the most useful tumour marker tor adenocarcinoma of the prostate. J Urol 145: 907-923
    • (1991) J Urol , vol.145 , pp. 907-923
    • Oesterling, J.E.1
  • 14
    • 0029005162 scopus 로고
    • Clinical evaluation of seven tumour markers in lung cancer diagnosis: Can any combination improve the results?
    • Plebani M, Basso D, Navaglia F, De-Paoli M, Tommasini A and Cipriani A (1995) Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results? Br J Cancer 72: 170-173
    • (1995) Br J Cancer , vol.72 , pp. 170-173
    • Plebani, M.1    Basso, D.2    Navaglia, F.3    De-Paoli, M.4    Tommasini, A.5    Cipriani, A.6
  • 15
    • 0027209937 scopus 로고
    • Serial measurements of tissue polypeptide specific antigen (TPS). PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer
    • Tarle M (1993) Serial measurements of tissue polypeptide specific antigen (TPS). PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer. Anticancer Res 13: 769-778
    • (1993) Anticancer Res , vol.13 , pp. 769-778
    • Tarle, M.1
  • 16
    • 0027479716 scopus 로고
    • Correlation of cell proliferation marker (TPS), Natural Killer (NK) activity and tumour load serotest (PSA) in untreated and treated prostatic tumours
    • Tarle M, Kovacic K and Kastelan M (1993) Correlation of cell proliferation marker (TPS), Natural Killer (NK) activity and tumour load serotest (PSA) in untreated and treated prostatic tumours. Anticancer Res 13: 215-218
    • (1993) Anticancer Res , vol.13 , pp. 215-218
    • Tarle, M.1    Kovacic, K.2    Kastelan, M.3
  • 17
    • 0028302956 scopus 로고
    • A more objective staging of advanced prostate cancer routine recognition of malignant endocrine structures: The assessment of serum TPS, PSA and NSE values
    • Tarle M, Erkovic-Grazio S, Kraljic I and Kovacic K (1994) A more objective staging of advanced prostate cancer routine recognition of malignant endocrine structures: the assessment of serum TPS, PSA and NSE values. Prostate 24: 143-148
    • (1994) Prostate , vol.24 , pp. 143-148
    • Tarle, M.1    Erkovic-Grazio, S.2    Kraljic, I.3    Kovacic, K.4
  • 18
    • 0028599490 scopus 로고
    • Role of multidrug resistance in tumours of the genitourinary tract
    • Theyer G and Hamilton G (1994) Role of multidrug resistance in tumours of the genitourinary tract. Urology 44: 942-950
    • (1994) Urology , vol.44 , pp. 942-950
    • Theyer, G.1    Hamilton, G.2
  • 19
    • 0027532535 scopus 로고
    • Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer
    • Yagoda A and Petralyk D (1993) Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer 71: 1098-1109
    • (1993) Cancer , vol.71 , pp. 1098-1109
    • Yagoda, A.1    Petralyk, D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.